Wilko Weichert

36.2k total citations · 6 hit papers
516 papers, 22.1k citations indexed

About

Wilko Weichert is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wilko Weichert has authored 516 papers receiving a total of 22.1k indexed citations (citations by other indexed papers that have themselves been cited), including 231 papers in Oncology, 175 papers in Molecular Biology and 160 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wilko Weichert's work include Cancer Genomics and Diagnostics (85 papers), Lung Cancer Treatments and Mutations (65 papers) and Pancreatic and Hepatic Oncology Research (54 papers). Wilko Weichert is often cited by papers focused on Cancer Genomics and Diagnostics (85 papers), Lung Cancer Treatments and Mutations (65 papers) and Pancreatic and Hepatic Oncology Research (54 papers). Wilko Weichert collaborates with scholars based in Germany, United States and Switzerland. Wilko Weichert's co-authors include Carsten Denkert, Manfred Dietel, Albrecht Stenzinger, Arne Warth, Jan Budczies, Aurelia Noske, Peter Schirmacher, Glen Kristiansen, Silvia Niesporek and Volker Gekeler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Angewandte Chemie International Edition.

In The Last Decade

Wilko Weichert

505 papers receiving 21.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer

2009 1.3k citations Carsten Denkert, Aurelia Noske et al. Journal of Clinical Oncology profile →
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

2013 836 citations Albrecht Stenzinger, Martin R. Sprick et al. profile →
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

2014 785 citations Wilko Weichert, Uwe Haberkorn et al. profile →
The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival

2012 542 citations Arne Warth, Thomas Muley et al. Journal of Clinical Oncology profile →
Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with ²²⁵Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding

2017 378 citations Wilko Weichert, Uwe Haberkorn et al. profile →
Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer

2023 141 citations Sebastian Foersch, Wilko Weichert et al. profile →

Peers

Countries citing papers authored by Wilko Weichert

Since Specialization

Citations

This map shows the geographic impact of Wilko Weichert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilko Weichert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilko Weichert more than expected).

Fields of papers citing papers by Wilko Weichert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilko Weichert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilko Weichert. The network helps show where Wilko Weichert may publish in the future.

Co-authorship network of co-authors of Wilko Weichert

This figure shows the co-authorship network connecting the top 25 collaborators of Wilko Weichert. A scholar is included among the top collaborators of Wilko Weichert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilko Weichert. Wilko Weichert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Postmortem Minimally Invasive Autopsy in Critically Ill COVID-19 Patients at the Bedside: A Proof-of-Concept Study at the ICU 2024 ·Diagnostics ·Tobias Lahmer, Gregor Weirich, Štefan Porubský, Sebastian Rasch, (unknown), (unknown), Peter J. Schüffler, Johanna Erber, (unknown), Claire Delbridge, (unknown), Samuel Jeske, (unknown), Adam Chaker, Markus Heim, Uwe Heemann, Roland M. Schmid, Wilko Weichert, Konrad Stock, Julia Slotta‐Huspenina	1
2	Comparison of assessment of programmed death-ligand 1 (PD-L1) status in triple-negative breast cancer biopsies and surgical specimens 2023 ·Journal of Clinical Pathology ·Aurelia Noske, Katja Steiger, Simone Ballke, Marion Kiechle, (unknown), Wilfried Roth, Wilko Weichert	8
3	Histology-Based Prediction of Therapy Response to Neoadjuvant Chemotherapy for Esophageal and Esophagogastric Junction Adenocarcinomas Using Deep Learning 2023 ·JCO Clinical Cancer Informatics ·(unknown), Saskia Ting, Sven‐Thorsten Liffers, Kelsey L. Pomykala, Katja Steiger, Markus Albertsmeier, Martin K. Angele, Sylvie Lorenzen, Michael Quante, Wilko Weichert, Jan Egger, Jens T. Siveke, Jens Kleesiek	6
4	How to use AI in pathology 2023 ·Genes Chromosomes and Cancer ·Peter J. Schüffler, Katja Steiger, Wilko Weichert	6
5	The role of claudin-6 in chromophobe renal cell carcinoma. 2023 ·PubMed ·Franziska Erlmeier, Stefanie Zschäbitz, Marie Mikuteit, Michael Autenrieth, Wilko Weichert, Arndt Hartmann, Sandra Steffens	2
6	The limits of molecular signatures for pancreatic ductal adenocarcinoma subtyping 2022 ·NAR Cancer ·(unknown), Jan Baumbach, Wilko Weichert, Katja Steiger, Markus List, Nicole Pfarr, Tim Kacprowski	4
7	Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk Subgroups 2021 ·Cancers ·(unknown), Miguel G. Silva, Björn Konukiewitz, (unknown), Katja Steiger, Kathrin Halfter, Jutta Engel, Paul Jank, Nicole Pfarr, Dirk Wilhelm, Sebastian Foersch, Carsten Denkert, Markus Tschurtschenthaler, Wilko Weichert, Moritz Jesinghaus	13
8	Distinct immune evasion in APOBEC ‐enriched, HPV ‐negative HNSCC 2020 ·International Journal of Cancer ·(unknown), Benedikt Obermayer, Konrad Klinghammer, Sebastian Ochsenreither, Denise Treue, Albrecht Stenzinger, Hanno Glimm, Stefan Fröhling, Thomas Kindler, Christian Brandts, Klaus Schulze‐Osthoff, Wilko Weichert, Ingeborg Tinhofer, Frederick Klauschen, Ulrich Keilholz, Dieter Beule, Damian Rieke	12
9	Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells 2019 ·Clinical Cancer Research ·Carmen Mota Reyes, Steffen Teller, Alexander Muckenhuber, Björn Konukiewitz, (unknown), Wilko Weichert, Helmut Frieß, Güralp O. Ceyhan, İhsan Ekin Demir	62
10	Composition and Clinical Impact of the Immunologic Tumor Microenvironment in Oral Squamous Cell Carcinoma 2018 ·The Journal of Immunology ·Melanie Boxberg, (unknown), Katja Steiger, Moritz Jesinghaus, (unknown), (unknown), Nicole Pfarr, Carolin Götz, Klaus Wolff, Wilko Weichert, Andreas Kolk	70
11	Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response 2017 ·Clinical Cancer Research ·Alexander Muckenhuber, Anne Berger, Anna Melissa Schlitter, Katja Steiger, Björn Konukiewitz, Andreas Trumpp, Roland Eils, Jens Werner, Helmut Friess, Iréne Esposito, Günter Klöppel, Güralp O. Ceyhan, Moritz Jesinghaus, Carsten Denkert, Marcus Bahra, Albrecht Stenzinger, Martin R. Sprick, Dirk Jäger, Christoph Springfeld, Wilko Weichert	61
12	CXCR4 Is a Potential Target for Diagnostic PET/CT Imaging in Barrett's Dysplasia and Esophageal Adenocarcinoma 2017 ·Clinical Cancer Research ·Hsin‐Yu Fang, (unknown), Margret Schottelius, (unknown), Haibo Liu, Michael Schauer, Stefan Stangl, Gabriele Multhoff, Katja Steiger, Carlos Gerngroß, Moritz Jesinghaus, Wilko Weichert, Anja A. Kühl, Antonia R. Sepulveda, Hans‐Jürgen Wester, Timothy C. Wang, Michael Quante	35
13	Comprehensive analysis of clinico-pathological data reveals heterogeneous relations between atherosclerosis and cancer 2014 ·Journal of Clinical Pathology ·Jan Budczies, Moritz von Winterfeld, Frederick Klauschen, (unknown), Jan‐Marcus Daniel, Arne Warth, Volker Endris, Carsten Denkert, Heriberto Pfeiffer, Wilko Weichert, Manfred Dietel, Daniel Wittschieber, Albrecht Stenzinger	13
14	Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma 2014 ·Carcinogenesis ·Andreas Schröck, (unknown), Friederike Göke, Petra M. Bareiss, Rebekka Schairer, Hui Wang, Wilko Weichert, Alina Franzen, Robert Kirsten, Tobias Van Bremen, Angela Queisser, Glen Kristiansen, Lynn E. Heasley, Friedrich Bootz, Claudia Lengerke, Sven Perner	64
15	The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival breakdown → 2012 ·Journal of Clinical Oncology ·Arne Warth, Thomas Muley, Michael Meister, Albrecht Stenzinger, Michael Thomas, Peter Schirmacher, Philipp A. Schnabel, Jan Budczies, Hans Hoffmann, Wilko Weichert	542
16	Combination of Phage Display and Molecular Grafting Generates Highly Specific Tumor‐Targeting Miniproteins 2012 ·Angewandte Chemie International Edition ·Frederic Zoller, Annette Markert, Philippe Barthe, (unknown), Wilko Weichert, Vasileios Askoxylakis, Annette Altmann, Walter Mier, Uwe Haberkorn	36
17	Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab–Docetaxel Treatment 2011 ·Clinical Cancer Research ·Ingeborg Tinhofer, Konrad Klinghammer, Wilko Weichert, Maren Knödler, Albrecht Stenzinger, Thomas Gauler, Volker Budach, Ulrich Keilholz	76
18	Atypical Protein Kinase C ζ Exhibits a Proapoptotic Function in Ovarian Cancer 2010 ·Molecular Cancer Research ·Irina Nazarenko, Marcel Jenny, Jana Keil, (unknown), (unknown), Jalid Sehouli, Stefan Legewie, (unknown), Wilko Weichert, Silvia Darb‐Esfahani, Manfred Dietel, Reinhold Schäfer, Florian Ueberall, Christine Sers	26
19	Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo 2008 ·Clinical Cancer Research ·Wilko Weichert, A.-E. Roske, Silvia Niesporek, Aurelia Noske, Ann‐Christin Buckendahl, Manfred Dietel, Volker Gekeler, Markus Boehm, Thomas Beckers, Carsten Denkert	299
20	Mass Spectrometry–Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors 2006 ·Cancer Research ·Carsten Denkert, Jan Budczies, Tobias Kind, Wilko Weichert, (unknown), Jalid Sehouli, Silvia Niesporek, Dominique Könsgen, Manfred Dietel, Oliver Fiehn	304

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact